Our Technology doesn't rely on guesswork
‍
We guide every therapy decision with data and biology

Pathway Advantage:
Begins with the patients own tumor tissue to ensure we capture the uniqueness of their cancer and mechanisms driving their cancer.

We collect tumor samples through surgical resection or biopsies to initiate multiomic profiling and ex vivo drug testing.

Pathway Advantage:
Captures comprehensive tumor signals beyond genomics for a fuller biological picture.

Extract multiomic signals from tumor biopsies to build a molecular map of the tumor.

Pathway Advantage:
Refines on real patient outcomes to generate more clinically-relevant predictions.

Train and run ML models to predict therapeutic response based on patient-specific biology.

Pathway Advantage:
Functionally validates therapies on the patient’s actual tumor — before treatment begins.

Use lab-grown biological avatars™ to test drugs directly on the patient’s own cancer tissue.

Pathway Advantage:
Deliver a platform that is accessible to clinicians to derive meaning behind our predictions and results and question the data generated by Pathway Bio.

We enable clinicians to be able to talk to the data and interrogate the data to guide their therapy strategies.

Pathway Advantage:
We report on actionable findings coupled with functionally tested therapies which can guide a clinicians therapeutic strategy.

Using agentic workflows and Natural Language Dashboard, we bring data to life.